dalteparin has been researched along with hydroxychloroquine in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 14 (93.33) | 2.80 |
Authors | Studies |
---|---|
Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
Bartoletti, M; Viale, P | 1 |
Fustini, E; Gennarini, S; Mattioli, M | 1 |
Fueyo-Rodriguez, O; Moreno-Sanchez, F; Palomar-Lever, A; Valente-Acosta, B | 1 |
Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E | 1 |
Cipriani, MS; Massabeti, R; Valenti, I | 1 |
Khan, MA | 1 |
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A | 1 |
Carhuactocto, A; Castillo, L; Del Castillo, R; Garcia, B; Giordano, FA; Martinez, D; Pinillos, L; Sarria, GJ; Sarria, GR | 1 |
Ferrari, SA; Muzzarelli, L; Piconi, S; Rossi, G; Sommaruga, S | 1 |
Akat, H; Laloglu, F; Orbak, Z | 1 |
Bianco, G; Boari, GEM; Bonetti, S; Bonzi, B; Braglia-Orlandini, F; Chiarini, G; Desenzani, P; Faustini, C; Ferrari-Toninelli, G; Guarinoni, V; Malerba, P; Mascadri, C; Nardin, M; Pasini, G; Rizzoni, D; Saottini, M; Turini, D; Tusi, C; Viola, S; Zanotti, E | 1 |
Berns, SA; Ershov, FI; Myasnikov, AL; Talyzin, PA | 1 |
Ahmed, WU; Alghoul, H; Alser, O; Alshammari, TM; Areia, C; Burn, E; Carter, W; Casajust, P; Cho, J; Dawoud, D; Duarte-Salles, T; Golozar, A; Gong, M; Hripcsak, G; Jonnagaddala, J; Kostka, K; Lai, LYH; Lane, JC; Liu, L; Lynch, KE; Matheny, ME; Mehta, PP; Morales, DR; Nyberg, F; Posada, JD; Prats-Uribe, A; Prieto-Alhambra, D; Recalde, M; Reich, C; Rijnbeek, PR; Roel, E; Ryan, PB; Schilling, LM; Sena, AG; Shah, K; Shah, NH; Subbian, V; Suchard, MA; Vizcaya, D; You, SC; Zhang, L; Zhang, Y; Zhu, H | 1 |
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S | 1 |
3 review(s) available for dalteparin and hydroxychloroquine
Article | Year |
---|---|
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Glucocorticoids; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Prednisolone; SARS-CoV-2; Spondylitis, Ankylosing | 2020 |
Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Combined Modality Therapy; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Humans; Hydroxychloroquine; Male; Middle Aged; Oxygen Inhalation Therapy; Peru; Radiotherapy Planning, Computer-Assisted; Thrombophilia; Tomography, X-Ray Computed | 2020 |
1 trial(s) available for dalteparin and hydroxychloroquine
Article | Year |
---|---|
[Interferon gamma in the treatment of patients with moderate COVID-19].
Topics: Aged; Ampicillin; Anti-Infective Agents; Anticoagulants; Azithromycin; Blood Pressure; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Hydroxychloroquine; Immunologic Factors; Interferon-gamma; Male; Middle Aged; Random Allocation; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vancomycin | 2021 |
11 other study(ies) available for dalteparin and hydroxychloroquine
Article | Year |
---|---|
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Azithromycin; Combined Modality Therapy; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Enoxaparin; Humans; Hydroxychloroquine; Hypertension; Male; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Thrombophilia; Tomography, X-Ray Computed; Valsartan | 2020 |
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; Cough; COVID-19; COVID-19 Drug Treatment; Diarrhea; Enoxaparin; Enzyme Inhibitors; Exanthema; Fever; Glucocorticoids; Heart Transplantation; Humans; Hydroxychloroquine; Hypoxia; Immunocompromised Host; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Nausea; Piperacillin, Tazobactam Drug Combination; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; SARS-CoV-2; Tachypnea; Treatment Outcome | 2020 |
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betacoronavirus; Bicarbonates; Ceftriaxone; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Enoxaparin; Enzyme Inhibitors; Fluid Therapy; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Respiration, Artificial; Rhabdomyolysis; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Azithromycin; China; Coronavirus Infections; COVID-19; Darunavir; Disease Progression; Enoxaparin; Humans; Hydroxychloroquine; Male; Middle Aged; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Ritonavir | 2020 |
A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
Topics: Anti-Bacterial Agents; Anticoagulants; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Dyspnea; Enoxaparin; Fatal Outcome; Fever; Humans; Hydroxychloroquine; Hypoxia; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2020 |
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report.
Topics: Anesthesia, Local; Antibiotic Prophylaxis; Anticoagulants; Antiviral Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Betacoronavirus; Blood Vessel Prosthesis Implantation; Contraindications, Procedure; Coronavirus Infections; COVID-19; Darunavir; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endovascular Procedures; Enoxaparin; Female; Humans; Hydroxychloroquine; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Intraoperative Complications; Intubation, Intratracheal; Middle Aged; Nasopharynx; Operating Rooms; Pandemics; Patient Isolation; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spinal Cord Ischemia; Vertebral Artery | 2020 |
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |
Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Prognosis; Retrospective Studies; Risk Factors; Ritonavir; Treatment Outcome | 2020 |
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
Topics: Administrative Claims, Healthcare; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Chemotherapy, Adjuvant; Child; Child, Preschool; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Electronic Health Records; Enoxaparin; Female; Fluoroquinolones; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Inpatients; Lopinavir; Male; Middle Aged; Republic of Korea; Ritonavir; Safety; SARS-CoV-2; Spain; Treatment Outcome; United States; Vitamin D; Young Adult | 2021 |
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey | 2022 |